Energenesis Biomedical Co (TPE:6657) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Energenesis Biomedical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Energenesis Biomedical Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Energenesis Biomedical Co's long-term debt to total assets ratio increased from Jun. 2023 (0.00) to Sep. 2024 (0.00). It may suggest that Energenesis Biomedical Co is progressively becoming more dependent on debt to grow their business.

Energenesis Biomedical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Energenesis Biomedical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Energenesis Biomedical Co LT-Debt-to-Total-Asset Chart

Energenesis Biomedical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.07

0.01

Energenesis Biomedical Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	0.01	0.01	-	-

Energenesis Biomedical Co LT-Debt-to-Total-Asset Calculation

Energenesis Biomedical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

LT Debt to Total Assets (A: Dec. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2022 )	/	Total Assets (A: Dec. 2022 )
	=	3.945	/	630.862
	=	0.01

Energenesis Biomedical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	2.307	/	673.224
	=	0.00

Energenesis Biomedical Co (TPE:6657) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Energenesis Biomedical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Energenesis Biomedical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Energenesis Biomedical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Energenesis Biomedical Co Ltd (TPE:6657) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 21, Lane 583, Ruiguang Road, 6th Floor -3, Neihu District, Taipei, TWN, 11492

Website

https://www.energenesis-biomedical.com

Energenesis Biomedical Co Ltd is a biomedicine company. It is engaged in businesses related to biologic experimentation and analysis, as well as new drug development.

Energenesis Biomedical Co Headlines

No Headlines